MedDataX Logo

Observational Study of Infants Born at 34 to 37 Weeks of Gestation Until the Age of 1 Year

NCT ID: NCT00550069

Last Updated: 2007-12-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-12-31

Study Completion Date

2009-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Late preterm infants are at an increased risk for short and long term morbidity (during the 1st year of life, their neurodevelopmental status may also be delayed as compared to infants born at term). The term "near term infants" is probably a deceiving one.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will include all near term infants born at 3 Israeli medical centers during a one year period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Distress Hypoglycemia Feeding Intolerance Jaundice Hypothermia Developmental Delay

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

late preterm infants near term infants outcome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Gestational age 34wks- 37wks
* Singleton
* Without chromosomal abnormalities or malformations

Exclusion Criteria

* No chromosomal abnormalities
* Malformations
Minimum Eligible Age

1 Hour

Maximum Eligible Age

30 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sheba Medical Center

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sheba Medical Cener

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Iris Morag, M.D

Role: PRINCIPAL_INVESTIGATOR

Sheba Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sheba Medical Center

Tel Litwinsky, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Iris Morag, MD

Role: CONTACT

Phone: +972-52-666-7393

Email: [email protected]

Lidia Gavis, MD

Role: CONTACT

Phone: 052-666-7360

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SHEBA-07-4821-IM-CTIL

Identifier Type: -

Identifier Source: org_study_id